// App-Quantinova.ai

P-210 : The outcomes and toxicity of FOLFIRINOX treatment in a cohort of patients with incurable pancreatic cancer treated in a single centre in Northern Ireland

Researchers

Presenter

  • O. Devlin

Principal Investigators

  • L. Gilroy

  • C. O'Neill

  • C. Purcell

  • M. Eatock

Medical Centers

  • Belfast Health and Social Care Trust, Belfast, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • L-leucovorin

  • Oxaliplatin

  • Irinotecan

  • FOLFIRINOX

  • Filgrastim

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved